Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Sales | 44,736,000 | 32,294,000 | 29,024,000 | 26,045,000 | 16,204,000 |
| Cost of Goods | 9,589,000 | 4,014,000 | 3,823,000 | 3,755,000 | 2,528,000 |
| Gross Profit | 35,147,000 | 28,280,000 | 25,201,000 | 22,290,000 | 13,676,000 |
| Operating Expenses | 30,892,000 | 16,689,000 | 15,312,000 | 17,163,000 | 9,127,000 |
| Operating Income | 4,255,000 | 11,591,000 | 9,889,000 | 5,127,000 | 4,549,000 |
| Other Income | -1,009,000 | 175,000 | 95,000 | 374,000 | -101,000 |
| Pre-tax Income | 3,246,000 | 11,766,000 | 9,984,000 | 5,501,000 | 4,448,000 |
| Income Tax | 1,614,000 | 2,599,000 | 2,433,000 | 1,946,000 | 1,244,000 |
| Net Income Continuous | 1,629,000 | 9,161,000 | 7,537,000 | 3,542,000 | 3,404,000 |
| Net Income Discontinuous | 2,311,000 | 375,000 | 251,000 | 184,000 | -20,000 |
| Net Income | $3,910,000 | $9,126,000 | $7,788,000 | $3,726,000 | $3,179,000 |
| EPS Basic Total Ops | 0.54 | 1.48 | 1.25 | 0.60 | 0.84 |
| EPS Basic Continuous Ops | 0.22 | 1.49 | 1.21 | 0.57 | 0.90 |
| EPS Basic Discontinuous Ops | 0.32 | 0.06 | 0.04 | 0.03 | -0.01 |
| EPS Diluted Total Ops | 0.54 | 1.46 | 1.22 | 0.59 | 0.82 |
| EPS Diluted Continuous Ops | 0.22 | 1.47 | 1.18 | 0.56 | 0.88 |
| EPS Diluted Discontinuous Ops | 0.32 | 0.06 | 0.04 | 0.03 | -0.01 |
| EBITDA(a) | $8,280,000 | $12,621,000 | $10,861,000 | $6,006,000 | $5,091,000 |